SCHEMBL23345472

SCHEMBL23345472

CCCCC/C=C\C/C=C\CCC/C=C/c1ccc[nH]1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRPV1 Q8NER1 2/20 0.46
GAA P10253 2/20 0.40
F7 P08709 2/20 0.39
F3 P13726 2/20 0.39
PPARG P37231 3/20 0.39
FFAR1 O14842 2/20 0.39
PPARD Q03181 2/20 0.39
PPARA Q07869 2/20 0.39
L3MBTL1 Q9Y468 2/20 0.39
MEN1 O00255 2/20 0.39
ALDH1A1 P00352 2/20 0.39
TP53 P04637 2/20 0.39
CYP3A4 P08684 2/20 0.39
MAPT P10636 2/20 0.39
HPGD P15428 2/20 0.39
ALOX15 P16050 2/20 0.39
KMT2A Q03164 2/20 0.39
CNR1 P21554 2/20 0.39
KDM4E B2RXH2 1/20 0.39
USP2 O75604 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16135284 0.97 TRPV1 (0.42) TRPV1F7F3PPARGFFAR1
SCHEMBL16135283 0.92 GAA (0.42) TRPV1GAAALDH1A1MAPTFAAH
SCHEMBL16135277 0.92 GAA (0.42) TRPV1GAAALDH1A1MAPTFAAH
SCHEMBL23345540 0.92 GAA (0.42) TRPV1GAAALDH1A1MAPTFAAH
SCHEMBL16162777 0.88 GAA (0.40) TRPV1GAAALDH1A1FAAHMGLL
SCHEMBL10384639 0.81 MAPT (0.40) GAAL3MBTL1MEN1ALDH1A1MAPT
SCHEMBL499774 0.76 GAA (0.45) GAAMEN1ALDH1A1MAPTALOX15
SCHEMBL16135393 0.76 RAB9A (0.39) GAAL3MBTL1ALDH1A1MAPTHPGD
SCHEMBL16135286 0.75 HIF1A (0.49) TRPV1F7F3CNR1CNR2
SCHEMBL5620989 0.71 MAPT (0.40) GAAL3MBTL1MEN1ALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11833129-B2 Thiophene compound for treatment of exfoliating glaucoma AVOSCIENCE, LLC (US) 2023-12-05 US disclosed
US-20210137876-A1 LIPIDIC FURAN, PYRROLE, AND THIOPHENE COMPOUNDS FOR TREATMENT OF CANCER, NEUROLOGICAL DISORDERS, AND FIBROTIC DISORDERS AVOSCIENCE, LLC (US) 2021-05-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210137876-A1 LIPIDIC FURAN, PYRROLE, AND THIOPHENE COMPOUNDS FOR TREATMENT OF CANCER, NEUROLOGICAL DISORDERS, AND FIBROTIC DISORDERS FAH, PHOSPHO1, FAP TRPV1 1190/4885GAA 1793/4885F7 923/4885
US-11833129-B2 Thiophene compound for treatment of exfoliating glaucoma TYMP, TDP1, TDP2 TRPV1 1396/4885GAA 580/4885F7 1983/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.